baber/WOPTO huggingface dataset:
Patent AU-3493297-A (AU)
Title: In-line roller skate
Inventor: MEIBOCK ANTONIN A
IPC: A43B5/04
Filed: 1997-06-18
Abstract: A skate for receiving a foot of a skater includes a frame holding in-line wheels. A rigid base is securely attached to the frame. An external heel counter extends upwardly from the base around the heel portion of the skate. An upper having an outer shell of substantially soft pliable material extends upwardly from the base. A substantially rigid internal heel counter is disposed beneath the outer shell. The internal heel counter extends around the heel area of the skate above the top of said external heel counter. A substantially rigid ankle support cuff is pivotally coupled to the internal heel counter and disposed beneath the outer shell.
Patent AU-3605993-A (AU)
Title: Treatment for inflammatory bowel disease
Inventor: LOBB ROY R
IPC: A61K38/00
Filed: 1993-02-02
Abstract: A method for the treatment of inflammatory bowel disease (IBD) is disclosed. The method comprises administration of an antibody, polypeptide or other molecule recognizing VLA-4, a surface molecule expressed on most types of white blood cells and involved in leukocyte adhesion to endothelium and other tissus in the gut.
Patent AU-3625184-A (AU)
Title: Optical element
Inventor: BYRON KEVIN CHRISTOPHER
IPC: G02F1/35
Filed: 1984-12-04
Abstract: An optical element is comprised of a length of polarisation-maintaining optical fibre and means for launching a pump signal into the fibre in order to induce birefringence therein. The amount of birefringence varies with the pump signal intensity. When a polarised signal is also launched into the fibre it is effected by the induced birefringence. In the extreme cases the element acts as a switch, permitting or preventing transmission of the polarised signal through the fibre. The fibre and signal wavelength may be such as to provide gain in a transmitted polarised signal. Two optical switches in series may comprise an optical AND gate.
Patent AU-3792285-A (AU)
Title: Method of transmitting information, encoding and decoding device
Inventor: IMMINK KORNELIS ANTONIE SCHOUH
IPC: G11B20/10
Filed: 1985-01-18
Abstract: A method of converting n-bit information words into m-bit code words, and the other way round, is described. The code words have a limited disparity. For every information word two code words are assigned to a group of information words, which code words can be derived from one another by inversion. A choice between these two code words is made to limit the digital sum value so as to obtain a d.c. free code. In order to obtain a further limitation of the digital sum value within the code words these code words are derived from each other by inversion and reversal.
Patent AU-3964689-A (AU)
Title: Collagen wound healing matrices and process for their production
Inventor: CHU GEORGE H
IPC: A61P37/00
Filed: 1989-06-28
Abstract: Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0.01 to 0.3 g/cm3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves an an effective sustained delivery system for synergistic combinations of FGF and TGF-B.
Patent AU-4126101-A (AU)
Title: Membrane module for the separation of fluid mixtures
Inventor: PEX PETRUS PAULUS ANTONIUS CAT
IPC: B01D65/08
Filed: 2001-02-23
Abstract: Apparatus for seperating of fluid mixtures. A number of tubular membranes are arranged parallel to each other. Each of the membranes has a inner lumen and the flow direction is from the exterior of the membrane to the inner lumen. Each tube is surrounded by a larger diameter feed tube and a gap is formed between the outside service of the tubular membrane and the inside service of the feed tube. This annulus provides a feed flow channel for the fluid mixture alongst the outer surface of the tubular membrane. The annulus has a first and second end each being connecting with means for entrance and discharge respectively of the feed flow and with means to direct the feed flow through the channels. The inner lumen of the tubular membranes are sealed from the annular gap and provided with a connection for the discharge of the permeate flow. <IMAGE>   <IMAGE>
Patent AU-4323393-A (AU)
Title: Polymer-bound paclitaxel derivatives
Inventor: MONGELLI NICOLA
IPC: A61K47/48
Filed: 1993-06-07
Abstract: A polymer conjugate consisting essentially of: from 90 to 99.9 mol % of units represented by the formula   <IMAGE>   from 0.1 to 5 mol % of units represented by the formula   <IMAGE>   wherein one of R1 and R2 is a copolymer residue of the formula   <IMAGE>   and the other one is hydrogen atom; from 0 to 9.9 mol % of units represented by the formula   <IMAGE>    wherein R is a phenyl or t-butoxy group, R3 is H or an acetyl group, A and A1 which may be the same or different, represent a chemical single bond, an amino acid residue or peptide spacer selected from  beta  Ala, Gly, Phe-Gly, Phe-Phe-, Leu-Gly, Val-Ala, Phe-Ala, Leu-Phe, Leu-Ala, Phe-Leu-Gly, Phe-Phe-Leu, Leu-Leu-Gly, Phe-Tyr-Ala, Phe-Gly-Phe, Phe-Phe-Gly, Phe-Leu-Gly-Phe, Gly-Phe-Leu-Gly-Phe,- beta Ala, Phe-Gly- beta Ala, Phe-Phe- beta Ala, Leu-Gly- beta Ala, Val-Ala- beta Ala, Phe-Ala- beta Ala, Leu-Phe- beta Ala, Leu-Gly- beta Ala, Phe-Leu-Gly- beta Ala, Phe-Phe-Leu  beta Ala, Leu-Leu-Gly- beta Ala, Phe-Tyr-Ala- beta Ala, Phe-Gly-Phe- beta , Phe-Phe-Gly  beta Ala, Phe-Leu-Gly-Phe- beta Ala or Gly-Phe-Leu-Gly-Phe- beta Ala. The compounds are endowed with antitumor activity and show improved water solubility and decreased toxicity in comparison with paclitaxel or its known analogs. A method for their preparation and pharmaceutical compositions containing them are also described.
Patent AU-4340597-A (AU)
Title: Staphylococcus aureus antigen
Inventor: FATTOM ALI IBRAHIM
IPC: G01N33/577
Filed: 1997-09-11
Abstract: A negatively-charged S. aureus antigen contains beta-hexosamine as a major carbohydrate component. S. aureus strains that carry the antigen account for nearly all of the clinically significant strains of S. aureus that are not Type 5 or Type 8 strains. The antigen can be used in combination with S. aureus Type 5 polysaccharide antigen and S. aureus Type 8 polysaccharide antigen to provide nearly 100% coverage of S. aureus infection. The antigen and antibodies to the antigen are useful in kits and assays for diagnosing S. aureus infection.
Patent AU-4618097-A (AU)
Title: Granulates comprising a water soluble compound and cellulose
Inventor: KOUTRIK ROBERTUS CORNELIS VAN
IPC: A61K9/20
Filed: 1997-08-14
Abstract: A granulate consisting of a water soluble active ingredient, up to and including 100 wt.% of a cellulose product, such as microcrystalline cellulose and up to and including 0.5 wt.% of a wet granulation binding agent is provided. The granulate is prepared by a wet granulation technique. Compositions based upon the said granulate are disclosed.
Patent AU-4697799-A (AU)
Title: Particulate acellular tissue matrix
Inventor: GRIFFEY EDWARD S
IPC: A61K35/36
Filed: 1999-06-18
Abstract: A method of processing an acellular tissue matrix to give a particulate acellular tissue matrix includes: cutting sheets of dry acellular tissue matrix into strips; cryofracturing the dry acellular tissue matrix strips at cryogenic temperatures; separating the resulting particles by size at cryogenic temperatures; and freeze drying the fraction of particles of desired size to remove any moisture that may have been absorbed to give a dry particulate acellular tissue matrix. Rehydration of the dry particulate acellular tissue matrix may take place just prior to use. The particulate acellular tissue may be applied to a recipient site, by way of injection, spraying, layering, packing, in-casing or combinations thereof. The particulate acellular tissue may further include growth and stimulating agents selected from epidermal growth factor, fibroblast growth factor, nerve growth factor, keratinocyte growth factor, platelet derived growth factor, vasoactive intestinal peptide, stem cell factor, bone morphogetic proteins, chondrocyte growth factor and combinations thereof. Other pharmaceutically active compounds may be combined with the rehydrated particulate material including: analgesic drugs; hemostatic drugs; antibiotic drugs; local anesthetics and the like to enhance the acceptance of the implanted particulate material. The particulate material product may also be combined with stem cells selected from mesenchymal stem cells, epidermal stem cells, cartilage stem cells, hematopoietic stem cells and combinations thereof.
Patent AU-4850101-A (AU)
Title: Compounds for targeting
Inventor: EPENETOS AGAMEMNON ANTONIOU
IPC: C12N15/13
Filed: 2001-03-28
Abstract: A compound comprising a target cell specific portion and a cytotoxic portion, characterised in that the cytotoxic portion of the compound is a constitutively active caspase or has the same apoptosis-inducing activity as a caspase. Alternatively, the invention provides a compound comprising a mediator portion and a cytotoxic portion, characterised in that the cytotoxic portion of the compound is a constitutively active caspase or has the same apoptosis-inducing activity as a caspase. Preferably, the cytotoxic portion is a constitutively active caspase-3, caspase-6 or caspase-7, and the target cell specific portion is and antibody specific for a tumour cell antigen, such an HMFG-1 antibody. The invention further provides nucleic acids encoding the compounds of the invention, and the use of such compounds in medicine, such as in the treatment of cancer.
Patent AU-5030085-A (AU)
Title: A process for the reprocessing of carbon containing wastes and biomass
Inventor: GIEHR AXEL
IPC: C10G1/06
Filed: 1985-11-22
Abstract: 1. Process for the hydrogenative reprocessing of carbon containing waste materials, with the exclusion of a process for hydrocracking of waste tires in the presence of a catalyst of an iron compound and an auxiliary catalyst of metal compounds of the group Cr, Mo, W, Se and Te, based on a synergistic catalyst action with sulfur, by treatment of the waste materials with hydrogen und/or hydrogen transferring solvents (hydrogen donor solvents), characterized in that mixtures of carbon containing waste materials of synthetic respectively predominantly synthetic origin are reacted with hydrogen and/or hydrogen containing gases at a temperature of 200-600 degrees C, preferably at a temperature of 200-540 degrees C, at a pressure of 30-500 bar, preferably of 50-450 bar and a residence time of 1 minute to 8 hours, preferably of 15 minutes to 6 hours and in the case of reaction with a hydrogen-donor-solvent at a temperature of 75-500 degrees C, preferably of 80-480 degrees C and a pressure of 1-300 bar.
Patent AU-5085796-A (AU)
Title: Circuit arrangement for dispersion compensation in optical transmission systems by means of an optical filter
Inventor: KOTTEN KLAUS
IPC: G02B6/34
Filed: 1996-04-24
Abstract: In a circuit arrangement for dispersion compensation in optical transmission systems by means of an optical filter, an optical transverse filter is provided as a negative dispersion filter, and which has a series of directional couplers which respectively follow one another at a spacing of  tau /2 and are operated as splitters. A series of directional couplers are provided which likewise follow one another at a spacing of  tau /2 and are operated as combiners, the second output of each directional coupler of the directional couplers operated as splitters leading in each case to the second input of the respectively corresponding directional coupler operated as a combiner.
Patent AU-5154985-A (AU)
Title: Fluoro coumarins and derivatives thereof as antilymphoedema agents
Inventor: GANDOLFI CARMELO A
IPC: A61K31/37
Filed: 1985-12-20
Abstract: A compound of the formulawherein hydrogen, fluorine, chlorine or bromine; B is fluorine, or when A is fluorine B may be hydrogen; R is hydrogen, C,-C<sub>e</sub> branched or unbranched alkyl, CH<sub>2</sub>BR, CH<sub>2</sub>Cl or substituted or unsubstituted phenyl; X is hydrogen, chlorine or bromine; one of R<sub>1</sub> and R<sub>2</sub> is hydrogen and the other is hydroxy or C<sub>1</sub>-C<sub>7</sub> branched or unbranched alkoxy unsubstituted or substituted by a dialkyl amino group, or R, and R<sub>2</sub>, taken together with the carbon atom to which they are linked, form the groupC=O: with the proviso that, when R and X are both hydrogenis a C=O group, and B is fluorine and A is hydrogen is useful as antilimphoedema agent.
Patent AU-5341494-A (AU)
Title: Dopamine receptor subtype ligands
Inventor: BROUGHTON HOWARD BARFF
IPC: A61P25/00
Filed: 1993-10-22
Abstract: PCT No. PCT/GB93/02190 Sec. 371 Date Apr. 20, 1995 Sec. 102(e) Date Apr. 20, 1995 PCT Filed Oct. 22, 1993 PCT Pub. No. WO94/10145 PCT Pub. Date May 11, 1994Compounds of formula (I)    <IMAGE>  (I)  wherein one of X and Y represents nitrogen, and the other of X and Y represents oxygen, sulphur or N-R2; Q represents a substituted five- or six- membered monocyclic heteroaliphatic ring which contains one nitrogen atom as the sole heteroatom and is linked to the five-membered heteroatomic ring containing the moieties X and Y via a carbon atom; as well as substituted 1,3-dioxopropane precursors thereto, are ligands for dopamine receptor subtypes within the body and are therefore useful in the treatment of disorders of the dopamine system, in particular schizophrenia.
Patent AU-5470798-A (AU)
Title: Liquid plastic film pouch with inner straw and machine and method of making
Inventor: LARSON RAYMOND L
IPC: B65B61/20
Filed: 1997-12-11
Abstract: A liquid product carrying plastic film pouch (10) having a straw (12) free-floating in the liquid product (11) is described. The liquid product (11) contained within the inner chamber (13) of the pouch occupies from about 60 % to about 90 % of the volume of the inner chamber (13) of the pouch and a portion of air from the remaining volume is evacuated in sufficient quantity to permit the side walls (14, 15) of the pouch to be collapsed against one another when the pouch is grasped by the hand of a user person. By collapsing the side walls (14, 15) together the straw (12) located within the liquid can be grasped and manipulated to puncture the plastic film pouch (1) to extend a portion (12') of the straw (12) exteriorly of the pouch whereby to extract liquid therefrom. The pouch (10) is made of a multilayer resin film having an inner sealant layer (26) formed of a linear low density ethylene-octene copolymer or very low density ethylene copolymer (octene or other copolymers) such that when the straw punctures the film, the inner sealant layer (26) forms a membrane about the straw which exhibits a self-sealing behavior so as to prevent leakage in the punctured region as liquid is extracted from the pouch (10) through the straw (12). The machine and method of fabrication is also disclosed.
Patent AU-5502286-A (AU)
Title: Mechanically sheared collagen implant material and method
Inventor: NGUYEN HOC M
IPC: A61L27/00
Filed: 1986-03-21
Abstract: An injectable collagen material composed of reconstituted, mechanically sheared atelopeptide collagen fibers. The material is prepared by passing reconstituted collagen fibers repeatedly through a rigid mesh screen, until a substantial raduction in fiber size and size-heterogeneity is achieved. The mechanically sheared fibers may be further crosslinked to improve implant characteristics.
Patent AU-5645080-A (AU)
Title: Penicillins
Inventor: WETZEL BERND
IPC: C07D499/70
Filed: 1980-03-14
Abstract: Compounds of the formula   <IMAGE>  and  <IMAGE>  wherein A is phenyl, p-hydroxy-phenyl, 2-thienyl, 3-thienyl or 3,4-disubstituted phenyl, where the substituents, which may be identical to or different from each other, are each chlorine, hydroxyl or methoxy; R is -NH-Z-X; Z is straight or branched alkylene of 1 to 6 carbon atoms or cycloalkylene of 3 to 6 carbon atoms; X is cyano, hydroxyl, mercapto, aminocarbonyl, aminosulfonyl,   <IMAGE>  <IMAGE> +TR OR1, OCOR1, SR1, SOR1 or SO2R1;   R1 is straight or branched alkyl of 1 to 4 carbon atoms or phenyl;  R2 is hydrogen or alkyl of 1 to 4 carbon atoms; and  R1 and R2, together with an adjacent nitrogen atom to which they are attached, form a 3- to 6-membered heterocyclic ring; and non-toxic, pharmacologically acceptable salts thereof formed with inorganic or organic bases.
Patent AU-5808300-A (AU)
Title: Method for securely transmitting protected data
Inventor: REIF HOLGER
IPC: H04Q7/38
Filed: 2000-05-15
Abstract: The invention relates to a method for the secure transmission of protected data from a first terminal (1) within a first security area (6) to a second terminal (2) within a second security area (10), which is different from the first security area. The inventive method comprises the following steps: providing useful data in the first terminal; generating the protected data in the first terminal by adding first security characteristics (8a) to the useful data; transmitting the protected data within the first security area to an area transformer (9), by a first communications connection (4), said area transformer being integrated into both the first and the second security areas; transforming at least some of the first security characteristics into second security characteristics (11a) by means of the area transformer; transmitting the protected data within the second security area to a second terminal, by a second communications connection (7). The protected data can then be converted back into useful data in said second terminal.
Patent AU-5839300-A (AU)
Title: Antigenic meningococcal peptides
Inventor: MASIGNANI VEGA
IPC: A61P31/04
Filed: 2000-07-13
Abstract: WO99/36544 discloses a large number of proteins from  Neisseria meningitidis.  The present invention relates to fragments of those proteins which comprise at least one antigenic determinant. Homologous sequences and proteins comprising these fragments are also disclosed.
Patent AU-5870298-A (AU)
Title: 1,4-dihydropyridin derivatives and their use in therapy
Inventor: DURET GERARD
IPC: C07D401/12
Filed: 1998-01-12
Abstract: PCT No. PCT/FR98/00042 Sec. 371 Date Jul. 8, 1999 Sec. 102(e) Date Jul. 8, 1999 PCT Filed Jan. 12, 1998 PCT Pub. No. WO98/31680 PCT Pub. Date Jul. 23, 1998Novel 1,4-DHP of the following structures are described having better therapeutic activities in coronary diseases: wherein n and R1 are as defined in the specification.
Patent AU-5920900-A (AU)
Title: Polymerization of alkylene oxides onto functionalized initiators
Inventor: CLEMENT KATHERINE S
IPC: B01J27/26
Filed: 2000-07-07
Abstract: Certain alcohol initiators containing halogen, aldehyde, ketone or nitro substitution can be alkoxylated with excellent efficiency and low production of by-products using a metal cyanide catalyst. The products contain halogen, aldehyde, ketone or nitro groups that can undergo subsequent reactions to form amino groups.
Patent AU-5922290-A (AU)
Title: Percutaneous lymphography
Inventor: WOLF GERALD L
IPC: A61K49/04
Filed: 1990-05-30
Abstract: Injectable contrast agents of great clinical importance for lymphography, characterized by non-water soluble particle sizes between about 5 or 10 nm and about 500 or 900 nm, which have selective distribution to lymph nodes upon percutaneous administration and can be imaged with millimeter resolution. Also disclosed are methods for performing percutaneous lymphography using these contrast agents.
Patent AU-5935590-A (AU)
Title: Orthopedic pillow
Inventor: BARON MARTIAL-CHARLES
IPC: A47G9/10
Filed: 1990-06-26
Abstract: PCT No. PCT/FR90/00468 Sec. 371 Date Jan. 17, 1992 Sec. 102(e) Date Jan. 17, 1992 PCT Filed Jun. 26, 1990 PCT Pub. No. WO91/01103 PCT Pub. Date Feb. 7, 1991.The present invention relates to an orthopedic pillow having seven functions essential for the prophylaxis and the therapy of difficulties in falling asleep, sleep problems, cervical pain, scapular pain and back pain, when they are associated with cervical-dorsal hypertonies. The orthopedic pillow of the present invention is characterized by its functional shape and by the possibility of adjusting the thickness of its different portions. This adjustment allows to precisely adjust the pillow to all occipital-cervical-dorsal confirmations in a given size.
Patent AU-6176694-A (AU)
Title: Enamels water-dilutable after neutralisation with bases
Inventor: WILFINGER WERNER
IPC: C09D201/00
Filed: 1994-03-08
Abstract: A water-dilutable coating after base neutralization comprises a polyhydroxyl-functional resin including a condensation resin such as a polyester or alkyd resin, and/or a polyhydroxyl-functional addition resin such as an acrylate resin or the reaction product of a carboxyl-functional acrylate resin and a hydroxyl-functional acrylate resin, and/or an emulsion copolymer, an at least partially monoalcohol-etherified amino resin, and a strong organic or inorganic acid crosslinking catalyst non-ionically blocked with a monoepoxide, a diepoxide or a lactone.
Patent AU-6196894-A (AU)
Title: Novel monomeric aminoplast crosslinking agents
Inventor: SZITA JENO GEORGE
IPC: C07D251/70
Filed: 1994-05-09
Abstract: A composition is provided represented by the formula: <CHEM> wherein the point of attachment of the isopropenyl group is meta-, para-, or a mixture thereof, and wherein each of R<1>, R<2>, R<3>, and R<4> is independently selected from the group consisting of hydrogen, hydroxymethyl, an alkoxymethyl, an aminoplast-containing group derived from condensation thereof, and mixtures of any of the preceding moieties. Furthermore provided is a process for preparing an alkoxymethylated aminoplast. The process comprises contacting melamine with TMI, contacting the adduct formed with formaldehyde, and contacting the hydroxymethylated adduct with an alcohol such as butanol. The composition according to the invention is e.g. useful as a cross-linking agent A curable composition comprising the monomeric aminoplast crosslinker and a polyfunctional active hydrogen-containing material is also provided. An method of coating using the curable composition to produce cured films or objects is also provided.
Patent AU-6230596-A (AU)
Title: Animal feed
Inventor: SAHLSTROM STEFAN
IPC: A23K1/14
Filed: 1996-06-14
Abstract: The present invention relates to animal feed with improved quality, improved resistance to undesirable bacterial strains and improved digestibility and to a process for preparing animal feed containing cereal involving cereal fermentation to produce a feed.
Patent AU-6400886-A (AU)
Title: Liquid crystal light-modulating materials
Inventor: DOANE WILLIAM J
IPC: G02F1/1333
Filed: 1986-09-16
Abstract: The spontaneous formation of liquid crystal microdroplets by regulated phase separation from a solution of their isotropic state in matrix-producing composition, the matrix being solid and light transmissive synthetic resin, during solidification of such matrix yields a light modulating material consisting essentially of microdroplets (11) of liquid crystal dispersed in the matrix (10).